European stocks are moving higher on Thursday as investors are optimistic about the results of a recent study on omicron which showed that the risk of hospitalization is lower with omicron compared to delta.
In particular, research from Imperial College London indicates that the risk of needing hospitalization for patients infected with the Omicron variant of Covid-19 is 40-45% lower than for those infected with the Delta variant. “In general, we find evidence that the risk of hospitalization with Omicron is reduced, compared to Delta, in all cases identified during the study period,” the researchers note.
Another study from South Africa – where the new strain was first identified – also shows a reduced risk of hospitalization and serious illness. The study found that people diagnosed with micronutrients in South Africa between October 1 and November 3 were 80% less likely to be hospitalized than other strains during the same period.
Analysts warn, however, that it is too early to know for sure whether Omicron is more or less dangerous, despite the encouraging data that has been announced so far. The rapid spread of the new mutation has forced many European governments to implement severely restrictive measures, again affecting economic activity.
On the dashboard, the STOXX 600 gains 0.2% to 479.41 points.
The German DAX is up 0.25% at 15,634.86 points, the French CAC 40 is moving with small gains of 0.1% to 7,061.91 points, while the British FTSE 100 is growing marginally 0.03%.
In the region, the Italian FTSE MIB gained 0.1%, while the Spanish IBEX 35 rose 0.5%.
.
I am Sophia william, author of World Stock Market. I have a degree in journalism from the University of Missouri and I have worked as a reporter for several news websites. I have a passion for writing and informing people about the latest news and events happening in the world. I strive to be accurate and unbiased in my reporting, and I hope to provide readers with valuable information that they can use to make informed decisions.
